Buscar resultados de ensayos clínicos
Lymphoma, T-Cell, Cutaneous - 27 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Study of Oral LBH589 in Adult Patients With Refractory/Resistant Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2007-06-21 Intervenciones: Drug: LBH589 Other Name: panobinostat |
Completed |
Nombre del estudio: Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma Condición: Cutaneous T-cell Lymphoma Fecha: 2007-11-05 Intervenciones:
|
Recruiting |
Nombre del estudio: A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma Condición: Persistent or Recurrent Cutaneous T-Cell Lymphoma Fecha: 2013-03-28 Intervenciones: Drug: E7777 administered by intravenous (i.v.) infusion over 60 minutes (+/-10 minutes) on 5 consecutive |
Terminated |
Nombre del estudio: Everolimus in Treating Cutaneous T-cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2012-04-02 Intervenciones: Drug: Everolimus The study drug everolimus will be self-ad |
Withdrawn |
Nombre del estudio: Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) Condición: Cutaneous T-cell Lymphoma (CTCL) Fecha: 2013-04-24 Intervenciones: Drug: Sirolimus 0.1% Ointment Sirolimus 0.1% ointment will be applied topically to all affected areas of |
Recruiting |
Nombre del estudio: Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas Condición:
Fecha: 2014-12-12 Intervenciones:
|
Completed |
Nombre del estudio: A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma Condición: Cutaneous T-Cell Lymphoma Fecha: 2008-08-29 Intervenciones: Drug: Enzastaurin 1125 mg loading dose then 500 mg, oral, daily, until disease progression |
Completed |
Nombre del estudio: Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study Condición: Cutaneous T-Cell Lymphoma Fecha: 2008-10-22 Intervenciones: Drug: Tazarotene Topical 0.1 cream - apply to lesions on alternate days and at 2 week interval increase |
Recruiting |
Nombre del estudio: Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma Condición: Cutaneous T-cell Lymphoma Fecha: 2014-02-11 Intervenciones:
|
Completed |
Nombre del estudio: Study Evaluating Two Dose Levels of Targretin Capsules in Patients With Refractory Cutaneous T-cell Lymphoma (CTCL) Condición: Refractory Cutaneous T-cell Lymphoma Fecha: 2009-11-03 Intervenciones:
|